# Ipamorelin Benefits Reported in Research: Bone, GH, and Body Composition

> Ipamorelin benefits reported in research: dose-dependent bone lengthening, higher bone mineral content, steroid-bone rescue, and a clean GH pulse. Every claim cited.

The bone-skeletal evidence first: longer bone, more mineral, steroid-bone rescue — then the GH and body-composition data. Preclinical, and cited.

## The gist

The ipamorelin benefits reported in research are, first and most concretely, about bone. In rats, ipamorelin made leg bones grow longer in a clean dose-response, raised the mineral content of bone, and partly rebuilt bone that steroids had broken down. Those are the strongest, best-measured outcomes in its file.

The rest follows from a clean pulse of growth hormone — the hormone that drives much of childhood growth and adult repair — without the cortisol or prolactin spillover older peptides caused. Reported downstream effects include recovery and body-composition shifts, but those are softer. Important caveat: every benefit on this page is from animals or community report, not human trials. The one human efficacy trial — for bowel recovery — failed [5]. Read these as a research record, not promises.

## Bone lengthening, dose by dose

The clearest benefit signal is longitudinal bone growth. Ipamorelin at 18, 90, and 450 microg/day SC (split three times daily, 15 days) raised the bone growth rate of adult female rats from 42 microm/day on vehicle to 44, 50, and 52 microm/day — a clean, dose-dependent climb [1]. (Longitudinal growth = lengthening at the growth plate, the cartilage zone where bones extend.)

What makes it interesting: total IGF-1, IGF binding proteins, and bone turnover markers did not change [1]. The bone grew without a measurable rise in the usual systemic growth-hormone messenger — pointing to a partly local, pulse-driven effect rather than a flood of circulating IGF-1.

## More mineral in the bone

Ipamorelin also raised how much mineral bone holds. At 0.5 mg/kg/day, delivered continuously by an implanted osmotic minipump for 12 weeks, it increased total tibial and vertebral bone mineral content (by DXA scan) in adult female rats versus vehicle [2]. (DXA = the same dual-energy X-ray scan used to measure human bone density.)

The nuance: cortical volumetric bone mineral density did not change [2]. So the gain came from larger bone dimensions, not denser bone material — the skeleton got bigger, not harder. Honest framing matters here: "more mineral content" and "denser bone" are not the same claim, and the study supports the first, not the second.

## Holding bone against steroids

Glucocorticoid steroids strip bone. Ipamorelin pushed back. At 100 microg/kg SC three times daily for 3 months, given alongside methylprednisolone, it raised the periosteal bone formation rate roughly four-fold versus the steroid alone, and increased maximum tetanic muscle tension [3]. (Periosteal = the outer surface layer where bone is laid down.)

A supporting study explains why this can work: methylprednisolone did not blunt ipamorelin's acute growth-hormone release, and the combination raised IGF-1 and recovered body weight versus steroid alone [9]. The growth-hormone pulse survives steroid suppression — the mechanistic basis for the bone rescue. Still rats, still preclinical.

## The clean GH pulse behind it

Every bone benefit traces to one thing: a selective growth-hormone pulse. Ipamorelin released growth hormone as potently as GHRP-6 (pig ED50 2.3 vs 3.9 nmol/kg) but, unlike GHRP-6, did not raise ACTH or cortisol even past 200-fold its growth-hormone ED50 [4]. That selectivity is the headline benefit researchers cared about: the upside of growth-hormone stimulation without the stress-hormone cost. It is also why ipamorelin keeps getting paired with GHRH analogs on the [ipamorelin benefits](/benefits) of a two-pathway approach — covered on the research page.

## Body composition and recovery

Beyond bone, the reported benefits get softer. In mice, two weeks of ipamorelin raised fat-pad weight and leptin — but it also raised those independently of growth hormone, so the body-composition story is not a simple "lean gains" claim [17]. Community accounts describe faster recovery and a gradually leaner look over weeks, which sit on the [Ipamorelin effects](/effects) page as anecdote, not measured outcomes. The honest summary: bone is the proven-in-animals benefit; the physique and recovery claims are real reports but unproven evidence.

---

A terminal read of the ipamorelin literature: bone data logged where the studies confirm it, the lone failed human trial left in plain view, no clinic behind the console and nothing here dosed or sold.